ADC Therapeutics SA (ADCT) — Dilution Risk Analysis

Current Snapshot

ADC Therapeutics SA (ADCT) has a DilutionWatch score of 50/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
127,667,695 Source
Public Float
100,412,332 Source
Float as % of Outstanding
78.7%

Dilution Risk Score

Score: 50/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

3 shelf registration or ATM offering filings detected in recent history.

Recent filing forms in the source payload: XBRL 1, 424B3 2, 4 4, EFFECT 1, S-3 1, 8-K 1.

FormFiledAccession
xbrl 2026-06-30 xbrl-3947-xbrl_warrant
424B3 2026-04-15 0000950103-26-005754
4 2026-04-02 0001104659-26-039359
424B3 2026-03-16 0000950103-26-003830
EFFECT 2026-03-16 9999999995-26-000834
S-3 2026-03-10 0000950103-26-003549
8-K 2026-02-23 0000950103-26-002466
4 2026-02-18 0001628280-26-009275
4 2026-02-18 0001628280-26-009278
4 2026-02-18 0001628280-26-009280

Dilution Risk Drivers

DriverStored ValueSource
Shelf registration capacity $37,500,000 Source
ATM offering capacity remaining $37,500,000 Source
Cash runway 18 months Source
Three-year share count growth 54.69% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 50/10) Source
Cash Runway
18 months Source
ATM Offering Capacity Remaining
$37,500,000 Source
Shelf Registration Capacity
$37,500,000 Source
Share Count Growth (3-Year)
54.69% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.